|
|
|
|
|
|
|
|
|
08.04.26 - 10:39
|
BlackRock, State Street Challenge Invesco′s Nasdaq-100 ETF Dominance (Benzinga)
|
|
|
BlackRock and State Street have threatened Invesco's decade-long dominance on the Nasdaq-100 ETF space, filing with the SEC to launch competing funds tracking the same index. QQQ is currently the only ETF tracking the Nasdaq 100 ETF and is one of the most successful ETFs with $375.5 billion in AUM. With expense ratios yet to be disclosed, fees may emerge as the biggest win factor, potentially driving meaningful flows and reshaping competition in one of the ETF market's most lucrative segments.
Importance Rank:
1
read more...
|
|
|
07.04.26 - 16:24
|
XBI vs. IBB: The Biotech ETF Showdown That Analysts Say Has a Clear Winner in 2026 (24/7 Wall St.)
|
|
|
Biotech has long been one of the strongest sector stories of the past year, and investors who got there early have been rewarded. As of April 2, 2026, the State Street SPDR S&P Biotech ETF (NYSE:XBI) has returned 40.80% over the trailing year as of April 2, 2026, more than double the category average of ... XBI vs. IBB: The Biotech ETF Showdown That Analysts Say Has a Clear Winner in 2026...
|
|
|
|
|
|
|
|
|
|
|
06.04.26 - 20:48
|
SPYM ETF′s Makeover Drives Assets to $120 (Bloomberg)
|
|
|
Matthew Bartolini, global head of research strategists at State Street Investment Management, joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ." SPDR Portfolio S&P 500 ETF (ticker: SPYM) has surged past $120 billion in assets after years in obscurity.
(Source: Bloomberg)...
|
|
|
06.04.26 - 15:18
|
Most Retirees Are Overlooking One of Vanguard’s Best Monthly Income Bond ETFs (24/7 Wall St.)
|
|
|
Call it habit. Call it decades of conventional wisdom pushed by financial advisors and DIY investors. Either way, a lot of retirees default to aggregate bond funds. It doesn't really matter whether it's from Vanguard, iShares, State Street, or Invesco. The structure is usually the same. You get a broad portfolio of thousands of U.S. ... Most Retirees Are Overlooking One of Vanguard's Best Monthly Income Bond ETFs...
|
|
|
06.04.26 - 15:06
|
MissionSquare appoints Katherine Lucas as Chief Marketing Officer (Business Wire)
|
|
|
WASHINGTON--(BUSINESS WIRE)--MissionSquare announced today that Katherine Lucas has joined the organization as chief marketing officer. In this role, Lucas oversees all aspects of MissionSquare's Marketing function, including brand, channel, digital, and sponsorship marketing. She reports directly to Andre Robinson, chief executive officer of MissionSquare.
"Marketing plays a critical role in shaping our brand's future, and we are delighted to welcome Katherine to our growing team at MissionSquare," said Robinson. "Katherine's breadth of experience will help differentiate our brand, expand our reach, and deliver greater value to our customers at every touchpoint as we continue to compete and grow in a dynamic marketplace.”
With more than 15 years of enterprise marketing experience, Lucas brings deep expertise in commercial growth, brand differentiation, and customer-centric transformation to MissionSquare. She previously served in several leadership roles at State Street, including hea...
|
|
|
|
|
03.04.26 - 16:18
|
This Biotech ETF Is Still Well Below Its 2021 Peak. Analysts Say That Is Exactly Why to Buy It. (24/7 Wall St.)
|
|
|
The biotech industry has been a robust roller-coaster over the last half decade. The State Street SPDR S&P Biotech ETF (NYSE: XBI), which tracks the biotech portion of the S&P 500, started in January 2021 as high as $175, when it was the height of the pandemic. Since then, it has dropped as much as ... This Biotech ETF Is Still Well Below Its 2021 Peak. Analysts Say That Is Exactly Why to Buy It.
The post This Biotech ETF Is Still Well Below Its 2021 Peak. Analysts Say That Is Exactly Why to Buy It. appeared first on 24/7 Wall St.....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
